作者:Joseph A Kozlowski、Derek B Lowe、Henry S Guzik、Guowei Zhou、Vilma B Ruperto、Ruth A Duffy、Robert McQuade、Gordon Crosby、Lisa A Taylor、William Billard、Herbert Binch、Jean E Lachowicz
DOI:10.1016/s0960-894x(00)00438-8
日期:2000.10
[4-(phenylsulfonyl)phenyl]methylpiperazine led to the discovery of 4-cyclohexyl-alpha-[4-[[4-methoxyphenyl(S)-sufinyl]phenyl]-1-pi perazineacetonitrile, 1, an M2 selective muscarinic antagonist. Affinity at the cloned human M2 receptor was 2.7 nM; the M1/M2 selectivity is 40-fold.
对[4-(苯磺酰基)苯基]甲基哌嗪的结构活性研究导致发现4-环己基-α-[4-[[[4-甲氧基苯基(S)-亚磺酰基]苯基] -1-pi过嗪乙腈,1,M2选择性毒蕈碱拮抗剂。在克隆的人M2受体上的亲和力为2.7 nM;M1 / M2选择性是40倍。